Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient

Transplantation

Volumn 92, Issue 2, 2011, Pages 163-169

  Damman, Jeffrey ^a   Seelen, Marc A ^a   Moers, Cyril ^a   Daha, Mohamed R ^a,b   Rahmel, Axel ^c   Leuvenink, Henri G ^a   Paul, Andreas ^d   Pirenne, Jacques ^e   Ploeg, Rutger J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Complement; Donor; Kidney; Rejection; Transplantation

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C4D; COMPLEMENT MEMBRANE ATTACK COMPLEX; MANNAN BINDING LECTIN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DEATH; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HUMAN; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN DEATH; CHILD; COMPLEMENT C4B; COMPLEMENT FACTOR B; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEATH; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; TISSUE DONORS; TRANSPLANTATION; YOUNG ADULT;

EID: 79960316724     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318222c9a0     Document Type: Article

References (33)

1. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation ofinflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69:405.
2. Terasaki PI, Cecka JM, Gjertson DW,etal.High survivalratesofkidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333:333.
3. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection ofrenal allografts from brain-dead donors. Ann Surg 2000; 232: 263.
4. Sanchez-Fructuoso AI, Prats D, Marques M, et al. Does donor brain death influence acute vascular rejection in the kidney transplant? Transplantation 2004; 78: 142.
5. Mc Laren AJ, Fuggle SV, Welsh KI, et al. Chronic allograft failure in human renal transplantation: A multivariate risk factor analysis. Ann Surg 2000; 232: 98.
6. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury.J Clin Invest 2000; 105: 1363.
7. De Vries B, Matthijsen RA, Wolfs TG, et al. Inhibition ofcomple-ment factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 2003; 75:375.
8. Peng Q, Li K, Anderson K, et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3a R interaction. Blood 2008; 111: 2452.
9. Peng Q, Li K, Wang N, et al. Dendritic cell function in allostimulation is modulated by C5a R signaling. J Immunol 2009; 183: 6058.
10. Berger SP, Roos A, Mallat MJ, et al. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5: 1361.
11. Roos A, Garred P, Wildenberg ME, et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004; 34: 2589.
12. Pratt JR, Basheer SA, Sacks SH. Local synthesis ofcomplement compo-nent C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582.
13. De Vries B, Kohl J, Leclercq WK, et al. Complement factor C5a medi-ates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003; 170: 3883.
14. Pratt JR, Jones ME, Dong J, et al. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/ reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 2003; 163: 1457.
15. Pratt JR, Hibbs MJ, Laver AJ, et al. Effects ofcomplement inhibition with soluble complement receptor-1 on vascular injury and inflamma-tion during renal allograft rejection in the rat. Am J Pathol 1996; 149: 2055.
16. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
17. Venkateswaran RV, Dronavalli V, Lambert PA, et al. The proinflam-matory environment in potential heart and lung donors: Prevalence and impact of donor management and hormonal therapy. Transplantation 2009; 88:582.
18. Koudstaal LG, Ottens PJ, Uges DR, et al. Increased intestinal permea-bility in deceased brain dead rats. Transplantation 2009; 88: 444.
19. Damman J, Nijboer WN,Schuurs TA,etal. Localrenalcomplement C3 induction by donor brain death is associated with reduced renal allo-graft function after transplantation. Nephrol Dial Transplant 2010 [Epub ahead ofprint].
20. Naesens M, Li L, Ying L, et al. Expression ofcomplement components differs between kidney allografts from living and deceased donors. JAm Soc Nephrol 2009; 20: 1839.
21. Gerard NP, Gerard C. The chemotactic receptor for human C5a ana-phylatoxin. Nature 1991; 349: 614.
22. Martin U, Bock D, Arseniev L, et al. The human C3a receptor is ex-pressed on neutrophils and monocytes, but not on Bor T lymphocytes. J Exp Med 1997; 186: 199.
23. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship be-tween duration of brain death and hemodynamic (in)stability on pro-gressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874.
24. Albrecht EA, Chinnaiyan AM, Varambally S, et al. C5a-induced gene expression in human umbilical vein endothelial cells. Am JPathol 2004; 164:849.
25. Monsinjon T, Gasque P, Chan P, et al. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelialcells. FASEB J 2003; 17: 1003.
26. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expres-sion of P-selectin in endothelial cells. J Clin Invest 1994; 94: 1147.
27. Kilgore KS, Flory CM, Miller BF, et al. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 1996; 149: 953.
28. Marsh JE, Farmer CK, Jurcevic S, et al. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001; 72: 1310.
29. Zhou W, Patel H, Li K, et al. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 2006; 107: 2461.
30. Carroll MC. The complement system in B cell regulation. Mol Immunol 2004; 41: 141.
31. Kootstra G, Daemen JH, Oomen AP. Categories ofnon-heart-beating donors. Transplant Proc 1995; 27: 2893.
32. Oosterlee A, Rahmel A. Eurotransplant International Foundation an-nual report 2007. Leiden, The Netherlands: Eurotransplant Interna-tional Foundation; 2007.
33. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7.